| Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection JF Creeden, AS Imami, HM Eby, C Gillman, KN Becker, J Reigle, E Andari, ... Biomedicine & Pharmacotherapy 138, 111437, 2021 | 58 | 2021 |
| Signature-based approaches for informed drug repurposing: targeting CNS disorders R Shukla, ND Henkel, K Alganem, A Hamoud, J Reigle, RS Alnafisah, ... Neuropsychopharmacology 46 (1), 116-130, 2021 | 48 | 2021 |
| Oxytocin’s anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach AS Imami, SM O’Donovan, JF Creeden, X Wu, H Eby, CB McCullumsmith, ... Physiological genomics 52 (9), 401-407, 2020 | 42 | 2020 |
| Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach SM O’Donovan, A Imami, H Eby, ND Henkel, JF Creeden, S Asah, ... Scientific reports 11 (1), 4495, 2021 | 27 | 2021 |
| Similarities and dissimilarities between psychiatric cluster disorders MA Smail, X Wu, ND Henkel, HM Eby, JP Herman, RE McCullumsmith, ... Molecular psychiatry 26 (9), 4853-4863, 2021 | 19 | 2021 |
| Kaleidoscope: a new bioinformatics pipeline web application for in silico hypothesis exploration of omics signatures K Alganem, R Shukla, H Eby, M Abel, X Zhang, WB McIntyre, J Lee, ... bioRxiv, 2020.05. 01.070805, 2020 | 17 | 2020 |
| Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity X Wu, R Shukla, K Alganem, X Zhang, HM Eby, EA Devine, E Depasquale, ... Molecular psychiatry 26 (12), 7699-7708, 2021 | 13 | 2021 |
| Cellular, molecular, and therapeutic characterization of pilocarpine-induced temporal lobe epilepsy ND Henkel, MA Smail, X Wu, HA Enright, NO Fischer, HM Eby, ... Scientific Reports 11 (1), 19102, 2021 | 10 | 2021 |
| Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS SM O’Donovan, H Eby, ND Henkel, J Creeden, A Imami, S Asah, X Zhang, ... Research Square, 2020 | 7 | 2020 |
| Molecular neurobiology of loss: a role for basolateral amygdala extracellular matrix MA Smail, BL Smith, R Shukla, K Alganem, HM Eby, JL Bollinger, ... Molecular Psychiatry, 1-13, 2023 | 3 | 2023 |
| Integrative omics for informed drug repurposing: Targeting CNS disorders R Shukla, ND Henkel, K Alganem, A Hamoud, J Reigle, RS Alnafisah, ... BioRxiv, 2020.04. 24.060392, 2020 | 2 | 2020 |
| Neuronal alterations in AKT isotype expression in schizophrenia R McCullumsmith, A Imami, H Eby, A Hamoud, W Ryan, S Sahay, T Arvay, ... | | 2024 |
| PAVER: Pathway Analysis Visualization with Embedding Representations W Ryan, AS Imami, H Eby, R McCullumsmith, R Shukla Translation: The University of Toledo Journal of Medical Sciences 11 (3), 2023 | | 2023 |
| Neuronal alterations in AKT isotype expression in schizophrenia E Devine, A Joyce, A Imami, A Hammoud, H Golchin, H Eby, E Shedroff, ... bioRxiv, 2023.06. 19.545479, 2023 | | 2023 |
| P381. The ATPome is a Key Player in the Pathophysiology of Major Depressive Disorder and Schizophrenia X Wu, X Zhang, R Shukla, A Joyce, H Eby, R McCullumsmith, ... Biological Psychiatry 91 (9), S241, 2022 | | 2022 |
| Comparative, Statistical, and Computational Genomics and Model Organism Databases: Oxytocin’s anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature … AS Imami, SM O’Donovan, JF Creeden, X Wu, H Eby, CB McCullumsmith, ... Physiological Genomics 52 (9), 401, 2020 | | 2020 |
| Fluoxetine as an Anti-Inflammatory Therapy in SARS-CoV-2 Infection (preprint) J Creeden, AS Imami, H Eby, C Gillman, K Becker, J Reigle, E Andari, ... | | 2020 |
| Kaleidoscope: A Bioinformatics Web Application for In Silico Exploration of Omics Data K Alganem, AS Imami, S Sahay, H Eby, TO Arvay, M Abel, X Zhang, ... | | |
| Supplementary Information Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS SM O’Donovan, H Eby, ND Henkel, J Creeden, A Imami, S Asah, X Zhang, ... | | |
